The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

“Our goal is to break down barriers and provide patients with safe and effective options they can rely on,” Patrik Jonsson, president of Lilly USA, said about the partnership in a press releas ...

Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA ...

The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics ...

president of Lilly Cardiometabolic Health and Lilly USA, in a statement. "These new vials not only help us meet the high demand for our obesity medicine but also broaden access for patients ...

and president of Lilly Cardiometabolic Health and Lilly USA. “Our goal is to break down barriers and provide patients with safe and effective options they can rely on.” Pick the best stocks ...

On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use ... of Lilly Cardiometabolic Health and Lilly USA Patrik Jonsson said in a statement. “Nearly half of clinical ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity," said Patrik Jonsson, president of Lilly USA.